A detailed history of 683 Capital Management, LLC transactions in Fibrogen Inc stock. As of the latest transaction made, 683 Capital Management, LLC holds 2,138,402 shares of FGEN stock, worth $727,056. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,138,402
Previous 2,150,000 0.54%
Holding current value
$727,056
Previous $1.91 Million 55.31%
% of portfolio
0.08%
Previous 0.17%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$0.33 - $1.26 $3,827 - $14,613
-11,598 Reduced 0.54%
2,138,402 $855,000
Q2 2024

Aug 14, 2024

BUY
$0.89 - $2.36 $267,000 - $708,000
300,000 Added 16.22%
2,150,000 $1.91 Million
Q1 2024

May 15, 2024

BUY
$0.73 - $2.73 $839,314 - $3.14 Million
1,149,746 Added 164.19%
1,850,000 $4.35 Million
Q4 2023

Feb 14, 2024

BUY
$0.38 - $0.91 $266,096 - $637,231
700,254 New
700,254 $623,000

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $31.9M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track 683 Capital Management, LLC Portfolio

Follow 683 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 683 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 683 Capital Management, LLC with notifications on news.